BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20131928)

  • 1. Apolipoprotein A5 in health and disease.
    Hubáček JA; Adámková V; Vrablík M; Kadlecová M; Zicha J; Kunes J; Pitha J; Suchánek P; Poledne R
    Physiol Res; 2009; 58 Suppl 2():S101-S110. PubMed ID: 20131928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants.
    Hubacek JA
    Clin Chem Lab Med; 2005; 43(9):897-902. PubMed ID: 16176166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apolipoprotein AV and triglyceridemia].
    Hubácek JA
    Cas Lek Cesk; 2004; 143(12):799-803. PubMed ID: 15730209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
    Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
    Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].
    Liu HK; Zhang SZ; Su ZG; Ma YX; Wang CT
    Yi Chuan; 2004 Nov; 26(6):953-6. PubMed ID: 15640132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
    Qi L; Liu S; Rifai N; Hunter D; Hu FB
    Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoprotein A-V: an important regulator of triglyceride metabolism.
    Kluger M; Heeren J; Merkel M
    J Inherit Metab Dis; 2008 Apr; 31(2):281-8. PubMed ID: 18415697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific effect of APOAV variant (Val153>Met) on plasma levels of high-density lipoprotein cholesterol.
    Hubacek JA; Skodová Z; Adámková V; Lánská V; Poledne R
    Metabolism; 2005 Dec; 54(12):1632-5. PubMed ID: 16311097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
    Niculescu LS; Vlădică M; Sima AV
    Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice.
    Pennacchio LA; Rubin EM
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):529-34. PubMed ID: 12615678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change.
    Hubacek JA; Bohuslavova R; Skodova Z; Pitha J; Bobkova D; Poledne R
    Clin Chem Lab Med; 2007; 45(3):316-20. PubMed ID: 17378725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apolipoprotein A5 gene: association with triglyceride metabolism and cardiovascular disease].
    Oliveira Sousa M; Alía P; Pintó X
    Med Clin (Barc); 2008 May; 130(20):787-93. PubMed ID: 18579034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men.
    Baum L; Tomlinson B; Thomas GN
    Clin Genet; 2003 May; 63(5):377-9. PubMed ID: 12752569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease.
    Dai W; Zhang Z; Yao C; Zhao S
    Lipids Health Dis; 2019 Dec; 18(1):220. PubMed ID: 31836003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
    Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC
    Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges.
    Martin S; Nicaud V; Humphries SE; Talmud PJ;
    Biochim Biophys Acta; 2003 Apr; 1637(3):217-25. PubMed ID: 12697303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice.
    Nelbach L; Shu X; Konrad RJ; Ryan RO; Forte TM
    J Lipid Res; 2008 Mar; 49(3):572-80. PubMed ID: 18056685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.
    Delgado-Lista J; Perez-Jimenez F; Ruano J; Perez-Martinez P; Fuentes F; Criado-Garcia J; Parnell LD; Garcia-Rios A; Ordovas JM; Lopez-Miranda J
    J Lipid Res; 2010 Jan; 51(1):63-73. PubMed ID: 19592705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.